Symbol="ADIL"
AssetType="Common Stock"
Name="Adial Pharmaceuticals Inc"
Description="Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia."
CIK="1513525"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4421300"
EBITDA="-11347651"
PERatio="None"
PEGRatio="None"
BookValue="2.77"
DividendPerShare="0"
DividendYield="0"
EPS="-10.16"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.966"
ReturnOnEquityTTM="-1.913"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-10.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.179"
EVToRevenue="-"
EVToEBITDA="-0.0585"
Beta="0.938"
num_52WeekHigh="15"
num_52WeekLow="3.125"
num_50DayMovingAverage="5.54"
num_200DayMovingAverage="7.49"
SharesOutstanding="1218000"
DividendDate="None"
ExDividendDate="None"
symbol="ADIL"
open="3.57"
high="3.70"
low="3.32"
price="3.63"
volume="34481.00"
latest_trading_day="2023-08-30"
previous_close="3.50"
change="0.14"
change_percent="3.8627%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="79"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="1617481"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.64"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="1150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0183.jpeg"
image_negative_thumbnail_id_2="1135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="981"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_positive_thumbnail_id_2="948"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0110.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
